# Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides

> **NCT07504029** · NA · RECRUITING · sponsor: **Chung Shan Medical University** · enrollment: 12 (estimated)

## Conditions studied

- People With Prediabetic

## Interventions

- **DIETARY_SUPPLEMENT:** BmpP® Momordica charantia Peptide Capsules

## Key facts

- **NCT ID:** NCT07504029
- **Lead sponsor:** Chung Shan Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-13
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07504029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07504029, "Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07504029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*